CERK and neuroblastoma: Specifically, the inhibition of this enzyme, by treatment with the active form of vitamin D3, 1,25-dihydroxivitamin D3, specific gene silencing, or with the pharmacological CERK inhibitor K1, led to a sharp depletion of intracellular C1P levels, and drastically reduced neuroblastoma cell proliferation [93].